Literature DB >> 11032626

Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?

R S Doody1, S N Azher, H A Haykal, J K Dunn, T Liao, L Schneider.   

Abstract

OBJECTIVE: To assess the relation between APO E genotype and MRI white matter changes in Alzheimer's disease. The APO epsilon4 allele is correlated with amyloid angiopathy and other neuropathologies in Alzheimer's disease and could be associated with white matter changes. If so, there should be a dose effect.
METHODS: 104 patients with probable Alzheimer's disease (NINCDS-ADRDA criteria) in this Alzheimer's Disease Research Centre were studied. Patients received MRI and APO E genotyping by standardised protocols. Axial MRI was scored (modified Schelten's scale) for the presence and degree of white matter changes and atrophy in several regions by a neuroradiologist blinded to genotype. Total white matter and total atrophy scores were also generated. Data analysis included Pearson's correlation for regional and total imaging scores and analysis of variance (ANOVA) (or Kruskal-Wallis) and chi(2) for demographic and disease related variables.
RESULTS: 30 patients had no epsilon4, 53 patients were heterozygous, and 21 patients were homozygous. The three groups did not differ in sex distribution, age of onset, age at MRI, MMSE, clinical dementia rating, or modified Hachinski ischaemia scores. There were no significant correlations between total or regional white matter scores and APO E genotype (Pearson correlation).
CONCLUSIONS: No correlation between total or regional white matter scores and APO E genotype was found. The pathogenesis of white matter changes in Alzheimer's disease may be independent of APO E genotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032626      PMCID: PMC1763391          DOI: 10.1136/jnnp.69.5.668

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.

Authors:  J Tian; J Shi; K Bailey; C L Lendon; S M Pickering-Brown; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

2.  Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease.

Authors:  Changsheng Wang; Glenn T Stebbins; David A Medina; Raj C Shah; Roland Bammer; Michael E Moseley; Leyla deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2010-04-01       Impact factor: 4.673

Review 3.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

Review 4.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

5.  Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition.

Authors:  Daniel Ferreira; Lena Cavallin; Tobias Granberg; Olof Lindberg; Carlos Aguilar; Patrizia Mecocci; Bruno Vellas; Magda Tsolaki; Iwona Kłoszewska; Hilkka Soininen; Simon Lovestone; Andrew Simmons; Lars-Olof Wahlund; Eric Westman
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

6.  Candidate-gene analysis of white matter hyperintensities on neuroimaging.

Authors:  Theresa Tran; Ioana Cotlarciuc; Sunaina Yadav; Nazeeha Hasan; Paul Bentley; Christopher Levi; Bradford B Worrall; James F Meschia; Natalia Rost; Pankaj Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-02       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.